Sub-dissociative Dose Ketamine in Treatment of Vaso-occlusive Pain Event in Children and Young Adults

Abroad (travel likely)RecruitingPHASE2

Conditions

Sickle Cell Disease · Vaso-Occlusive Pain Episode in Sickle Cell Disease · Ketamine Infusion · Pain Management · Vaso-Occlusive Crises

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Harbor UCLA Medical Center, Torrance, California, United States
Contact: Study coordinator (Cynthia Luo, MD) · cluo2@dhs.lacounty.gov · 310-222-2345
Contact: Principal Investigator (Mohsen Saidinejad, MD)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)

Sickle Cell Disease

Abroad (travel likely)RecruitingPHASE2

Little Rock, United States · Hollywood, United States

Cannabidiol in Sickle Cell Disease

Sickle Cell Disease

Abroad (travel likely)RecruitingPHASE1, PHASE2

Manhattan, United States

Morphine Clearance and Glomerular Filtration in Sickle Cell Patients in Crisis in Intensive Care

Sickle Cell Disease · Glomerular Hyperfiltration · Sickle Cell Nephropathy

Abroad (travel likely)Recruiting

Tours, France · Créteil, France

Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain

Pain · Sickle Cell Disease

Abroad (travel likely)Recruiting

Mobile, United States · Los Angeles, United States